局部特兰克萨姆酸和维生素C的组合治疗耐火性黑色素瘤
Jerome Kaikati1, Nizar El Bcherawi1, Jad Abou Khater1
1All authors are with the Dermatology department and Faculty of Medicine at Saint-Joseph University in Beirut, Lebanon.
局部使用的tranexamic acid (TA) 2%与维生素C 2%相结合,显示出治疗耐药性黑色素瘤的前景. 这种组合为中东等高紫外线指数地区的患者提供了更安全的替代方案.
科学领域:
- 皮肤病学 皮肤病学
- 化品科学 化品科学
背景情况:
- 梅拉斯马是一种常见的皮肤疾病,特别流行在中东.
- 现有的治疗方法往往是无效的,特别是在紫外线辐射高的地区.
- 需要针对黑色素瘤的新型治疗方案.
研究的目的:
- 为了评估2%的三胺酸 (TA) 和2%的维生素C的局部组合治疗耐药性黑色素的疗效.
- 评估治疗对地中海人口中乳腺瘤严重程度,生活质量和医生评估的影响.
主要方法:
- 一项前性干预试点研究,涉及10名患有耐药性乳腺瘤的女性.
- 参与者每晚使用2%的TA和2%的维生素C的局部配方,持续八周.
- 测量结果包括梅拉斯马区域和严重性指数 (MASI),梅拉斯马生活质量量量表 (MelasQoL) 和医生全球评估 (PGA).
主要成果:
- 从基线到第8周的MASI得分显著降低 (p<0.01).
- 观察到MelasQoL得分的改善,尽管在第8周没有统计学意义 (p=0.14).
- 医生全球评估显示了积极的趋势,没有报告的主要副作用.
结论:
- 局部2%的TA和2%的维生素C组合是一种潜在的有效治疗高紫外线指数区域的耐药性黑色素.
- 这种组合为潜在有害的漂白治疗提供了一个更安全的替代方案.
- 需要进一步的研究来证实这些发现在更大的群体中.
更多相关视频
03:47Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
09:52Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer
Published on: April 26, 2018
相关概念视频
Venous Thrombosis III: Interprofessional Care
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
